
JPXFinancial ServicesFinancial - Conglomerates
Latest quote
¥3,252
−¥38.00 · -1.16%
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
Latest quote
¥3,252
−¥38.00 · -1.16%
Regular session · JST · Market data may be delayed.
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
Day range
Current ¥3,252
52-week range
Current ¥3,252
Regular session · JST · Market data may be delayed.
SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.
Day range
Current ¥3,252
52-week range
Current ¥3,252
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 1.9T JPY | 1.35T JPY | 1.19T JPY | 911.97B JPY | 650.48B JPY |
| Cost of goods sold | 771.84B JPY | 384.87B JPY | 359.59B JPY | 279.06B JPY | 276.52B JPY |
| Gross profit | 1.12T JPY | 968.76B JPY | 829.91B JPY | 632.92B JPY | 373.96B JPY |
| Operating expenses | 608.18B JPY | 361.71B JPY | 415.93B JPY | 337.57B JPY | 169.23B JPY |
| Interest income | 889.46B JPY | 713.99B JPY | 569.88B JPY | 445.04B JPY | 283.83B JPY |
| Interest expense | — | 239.44B JPY | 209.65B JPY | 122.46B JPY | 42.16B JPY |
| Depreciation and amortization | 67.66B JPY | 59.66B JPY | 53.74B JPY | 54.03B JPY | 32.11B JPY |
| Operating income | 516.59B JPY | 607.05B JPY | 413.98B JPY | 295.35B JPY | 204.72B JPY |
| Net income | 427.58B JPY | 162.12B JPY | 87.24B JPY | 35.45B JPY | 366.85B JPY |
Company facts updated Sep 11, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥90.00
2025 complete year+38.5% since 2021
2026 partial: ¥75.00
¥65.00
2,021
¥75.00
2,022
¥75.00
2,023
¥80.00
2,024
¥90.00
2,025
¥75.00
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 29, 2026 | ¥30.00Semi-Annual | Sep 30, 2026 | Sep 29, 2026 |
Dividend | Mar 30, 2026 | ¥75.00Semi-Annual | Mar 31, 2026 | Jun 8, 2026 |
Dividend | Sep 29, 2025 | ¥40.00Semi-Annual | Sep 30, 2025 | Dec 15, 2025 |
Dividend | Mar 28, 2025 | ¥140Semi-Annual | Mar 31, 2025 | Jun 9, 2025 |
Dividend | Sep 27, 2024 | ¥30.00Annual | Sep 30, 2024 | Dec 16, 2024 |
Dividend | Mar 28, 2024 | ¥130Special | Mar 31, 2024 | Jun 7, 2024 |
Ex-dividend Sep 29, 2026
¥30.00
Semi-Annual
Record Sep 30, 2026 · Payment Sep 29, 2026
Ex-dividend Mar 30, 2026
¥75.00
Semi-Annual
Record Mar 31, 2026 · Payment Jun 8, 2026
Ex-dividend Sep 29, 2025
¥40.00
Semi-Annual
Record Sep 30, 2025 · Payment Dec 15, 2025
Ex-dividend Mar 28, 2025
¥140
Semi-Annual
Record Mar 31, 2025 · Payment Jun 9, 2025
Ex-dividend Sep 27, 2024
¥30.00
Annual
Record Sep 30, 2024 · Payment Dec 16, 2024
Ex-dividend Mar 28, 2024
¥130
Special
Record Mar 31, 2024 · Payment Jun 7, 2024
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Core TOPIX ETF1475.T5.71B0.20%2.92T JPY0.05%¥410.4-1.23%
iShares JPX-Nikkei 400 ETF1364.T1.76B0.29%598.51B JPY0.05%¥3,668-1.24%
Vanguard Total International Stock ETFVXUS147.79M0.02%646.2B USD0.05%$86.28-1.29%
Vanguard FTSE Developed Markets ETFVEA98.34M0.03%315B USD0.03%$71.92-1.24%
iShares Core MSCI EAFE ETFIEFA85.2M0.04%196.63B USD0.07%$98.51-0.92%
iShares MSCI Japan ETFEWJ48.33M0.20%23.51B USD0.49%$96.44-0.58%
Dimensional - International Value ETFDFIV47.4M0.21%22.41B USD0.27%$58.02-0.48%
WisdomTree Japan Hedged Equity FundDXJ45.9M0.62%6.99B USD0.48%$173.47+0.09%
iShares Core TOPIX ETF1475.T
iShares JPX-Nikkei 400 ETF1364.T
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Developed Markets ETFVEA
iShares Core MSCI EAFE ETFIEFA
iShares MSCI Japan ETFEWJ
Dimensional - International Value ETFDFIV
WisdomTree Japan Hedged Equity FundDXJAI-generated and delayed market data for informational and educational purposes only. Not investment advice.